Compare Stocks › BAX vs JNJ

Baxter International Inc. (BAX) vs Johnson & Johnson (JNJ): Which Is the Better Buy in 2026?

As of 2026-11-01, BAX is fairly valued at $23, with a DCF intrinsic value of $23 and a margin of safety of -0%. JNJ is overvalued at $273, with an intrinsic value of $203 and a margin of safety of -35%. Of the two, BAX has the wider margin of safety.

BAX
Baxter International Inc.
$23.00
VS
JNJ
Johnson & Johnson
$273.20

Rewards

BAX
  • ★FCF yield of 10.3% is historically attractive — the business generates significant cash relative to its price.
JNJ
  • ★Johnson & Johnson has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • ★Gross margin of 67.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★Johnson & Johnson scores 90/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.

Risks

BAX
  • ⚠PEG ratio of 36.68 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • ⚠Free cash flow has declined at a 17.5% CAGR over the past 4 years — a concerning trend.
JNJ
  • ⚠FCF yield of 2.8% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • ⚠Trailing P/E of 41.5x is 108% above the historical average of 20.0x — the stock trades at a premium to its own history.
  • ⚠PEG ratio of 3.07 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
BAX
JNJ
Valuation
$1.22B
Free Cash Flow
$18.50B
10.27%
FCF Yield
2.81%
N/A
Trailing P/E
41.46
11.25
Forward P/E
23.52
Quality & Moat
5.93%
ROIC
16.01%
-9.04%
ROE
20.02%
33.37%
Gross Margin
67.77%
36.68
PEG Ratio
3.07
Balance Sheet Safety
1.06
Net Debt / Equity
0.34
N/A
Interest Coverage
N/A
3.73
Net Debt / EBITDA
0.79
0.17%
Dividend Yield
1.96%
BAX: 2Ties: 1JNJ: 8
BAXJNJ

Historical Fundamentals

Learn more →
BAX

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

JNJ

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
BAX
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-474.0M
Δ Market Cap
$-15.88B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
JNJ
$0.91
created per $1 retained over 3 years
Mediocre Allocator
Σ Retained
$40.05B
Δ Market Cap
+$36.63B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
BAX
0.1% Overvalued
Price is 0.1% above estimated fair value
Current Price: $23.00
Fair Value: $22.97
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
JNJ
34.7% Overvalued
Price is 34.7% above estimated fair value
Current Price: $273.20
Fair Value: $202.84
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
BAX

What growth rate is the market pricing in at $23?

+4.1%
Market-Implied FCF Growth Rate

Market pricing in significantly higher growth than history — aggressive.

JNJ

What growth rate is the market pricing in at $273?

+9.9%
Market-Implied Owner Earnings Growth
Standard FCF implies +16.1%

The market implies +9.9% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +16.1%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
BAX
42/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving margin stability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
JNJ
90/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
BAX

Insufficient data for Beneish M-Score calculation (requires 2+ years).

JNJ
-2.31
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
BAX
Insiders 0.3%Institutions 109.5%
No. of Institutional Holders976
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
JNJ
Insiders 0.1%Institutions 76.8%Retail & Other 23.2%
No. of Institutional Holders5,842
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
BAX
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
JNJ
0
Buys (3M)
1
Buys (12M)
Total value (12M): $257,688
MORIKIS JOHN G
Director
$257,688
@ $206.15 · 2025-11-26
WEINBERGER MARK A
Director
$147,220
@ $147.22 · 2024-12-12
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
BAX
0
Sells (3M)
0
Sells (12M)
No open market insider sales found.
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
JNJ
5
Sells (3M)
14
Sells (12M)
Total value (12M): $128.54M
SCHMID TIMOTHY
Officer
$9.23M
@ $274.74 · 2026-09-02
TAUBERT JENNIFER L
Officer
$3.95M
@ $263.36 · 2026-08-17
DUATO JOAQUIN BOIX
Chief Executive Officer
$32.20M
@ $261.17 · 2026-08-13
FORMINARD ELIZABETH
Officer
$4.09M
@ $257.00 · 2026-08-06
DUATO JOAQUIN BOIX
Chief Executive Officer
$12.52M
@ $258.15 · 2026-08-05
BROADHURST VANESSA
Officer
$5.79M
@ $251.27 · 2026-07-20
WENGEL KATHRYN E
Chief Technology Officer
$2.41M
@ $241.15 · 2026-06-11
DECKER ROBERT J
Officer
$1.01M
@ $247.87 · 2026-02-27
SCHMID TIMOTHY
Officer
$324,763
@ $245.66 · 2026-02-20
SCHMID TIMOTHY
Officer
$5.53M
@ $244.33 · 2026-02-18
SWANSON JAMES D
Chief Technology Officer
$15.11M
@ $243.39 · 2026-02-17
BROADHURST VANESSA
Officer
$1.51M
@ $243.39 · 2026-02-17
WOLK JOSEPH J
Chief Financial Officer
$21.77M
@ $242.80 · 2026-02-17
REED JOHN C
Officer
$13.11M
@ $243.00 · 2026-02-17
REED JOHN C
Officer
$4.19M
@ $192.71 · 2025-10-17
TAUBERT JENNIFER L
Officer
$10.04M
@ $177.81 · 2025-09-04
DUATO JOAQUIN BOIX
Chief Executive Officer
$22.55M
@ $179.21 · 2025-08-22
WOLK JOSEPH J
Chief Financial Officer
$2.98M
@ $176.91 · 2025-08-15
REED JOHN C
Officer
$3.13M
@ $163.55 · 2025-07-17
DECKER ROBERT J
Officer
$1.16M
@ $165.88 · 2025-02-25
SCHMID TIMOTHY
Officer
$62,928
@ $156.15 · 2025-02-18
WOLK JOSEPH J
Chief Financial Officer
$2.00M
@ $153.89 · 2025-02-07
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
BAX
FearGreed
😨Fear(37/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
JNJ
FearGreed
😏Greed(67/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
BAX
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (37)
JNJ
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (67)
View BAX Full AnalysisView JNJ Full Analysis

Frequently Asked Questions: BAX vs JNJ

Is Baxter International Inc. or Johnson & Johnson more undervalued in 2026?▼

Based on our discounted cash flow model, BAX trades at a -0.1% margin of safety (intrinsic value $23 vs. price $23), compared to JNJ's -34.7% margin of safety (intrinsic $203 vs. $273).

Which stock has a wider economic moat, Baxter International Inc. or Johnson & Johnson?▼

JNJ scores 90/100 (Wide moat), while BAX scores 42/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Baxter International Inc. in financial distress?▼

BAX's Altman Z-Score of 2.2 places it in the Grey zone, signaling elevated bankruptcy risk. JNJ scores 3.5 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Baxter International Inc. or Johnson & Johnson?▼

Baxter International Inc. (BAX) generates a 10.3% free cash flow yield, compared to Johnson & Johnson's 2.8%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Baxter International Inc. or Johnson & Johnson?▼

JNJ earns 16.0% ROIC versus BAX's 5.9%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Baxter International Inc.'s or Johnson & Johnson's?▼

JNJ's dividend earns a safety score of 79/100 (Safe), compared to BAX's 35/100 (Unsafe). JNJ has raised its dividend for 3 consecutive years.

BAX vs JNJ: Which Is the Better Buy in 2026? | SafetyMargin.io